These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 12686153)

  • 1. Crystal structure of rabbit muscle glycogen phosphorylase a in complex with a potential hypoglycaemic drug at 2.0 A resolution.
    Oikonomakos NG; Chrysina ED; Kosmopoulou MN; Leonidas DD
    Biochim Biophys Acta; 2003 Apr; 1647(1-2):325-32. PubMed ID: 12686153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 1.76 A resolution crystal structure of glycogen phosphorylase B complexed with glucose, and CP320626, a potential antidiabetic drug.
    Oikonomakos NG; Zographos SE; Skamnaki VT; Archontis G
    Bioorg Med Chem; 2002 May; 10(5):1313-9. PubMed ID: 11886794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new allosteric site in glycogen phosphorylase b as a target for drug interactions.
    Oikonomakos NG; Skamnaki VT; Tsitsanou KE; Gavalas NG; Johnson LN
    Structure; 2000 Jun; 8(6):575-84. PubMed ID: 10873856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allosteric inhibition of glycogen phosphorylase a by the potential antidiabetic drug 3-isopropyl 4-(2-chlorophenyl)-1,4-dihydro-1-ethyl-2-methyl-pyridine-3,5,6-tricarbo xylate.
    Oikonomakos NG; Tsitsanou KE; Zographos SE; Skamnaki VT; Goldmann S; Bischoff H
    Protein Sci; 1999 Oct; 8(10):1930-45. PubMed ID: 10548038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of the potential antitumour agent indirubin-5-sulphonate at the inhibitor site of rabbit muscle glycogen phosphorylase b. Comparison with ligand binding to pCDK2-cyclin A complex.
    Kosmopoulou MN; Leonidas DD; Chrysina ED; Bischler N; Eisenbrand G; Sakarellos CE; Pauptit R; Oikonomakos NG
    Eur J Biochem; 2004 Jun; 271(11):2280-90. PubMed ID: 15153119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glutathione-dependent reduction of arsenate by glycogen phosphorylase responsiveness to endogenous and xenobiotic inhibitors.
    Gregus Z; Németi B
    Toxicol Sci; 2007 Nov; 100(1):44-53. PubMed ID: 17693424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FR258900, a potential anti-hyperglycemic drug, binds at the allosteric site of glycogen phosphorylase.
    Tiraidis C; Alexacou KM; Zographos SE; Leonidas DD; Gimisis T; Oikonomakos NG
    Protein Sci; 2007 Aug; 16(8):1773-82. PubMed ID: 17600143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystallographic studies on acyl ureas, a new class of glycogen phosphorylase inhibitors, as potential antidiabetic drugs.
    Oikonomakos NG; Kosmopoulou MN; Chrysina ED; Leonidas DD; Kostas ID; Wendt KU; Klabunde T; Defossa E
    Protein Sci; 2005 Jul; 14(7):1760-71. PubMed ID: 15987904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic and crystallographic studies of glucopyranosylidene spirothiohydantoin binding to glycogen phosphorylase B.
    Oikonomakos NG; Skamnaki VT; Osz E; Szilágyi L; Somsák L; Docsa T; Tóth B; Gergely P
    Bioorg Med Chem; 2002 Feb; 10(2):261-8. PubMed ID: 11741774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The binding of β-d-glucopyranosyl-thiosemicarbazone derivatives to glycogen phosphorylase: A new class of inhibitors.
    Alexacou KM; Tenchiu Deleanu AC; Chrysina ED; Charavgi MD; Kostas ID; Zographos SE; Oikonomakos NG; Leonidas DD
    Bioorg Med Chem; 2010 Nov; 18(22):7911-22. PubMed ID: 20947361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis of the synergistic inhibition of glycogen phosphorylase a by caffeine and a potential antidiabetic drug.
    Tsitsanou KE; Skamnaki VT; Oikonomakos NG
    Arch Biochem Biophys; 2000 Dec; 384(2):245-54. PubMed ID: 11368311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ternary complex crystal structures of glycogen phosphorylase with the transition state analogue nojirimycin tetrazole and phosphate in the T and R states.
    Mitchell EP; Withers SG; Ermert P; Vasella AT; Garman EF; Oikonomakos NG; Johnson LN
    Biochemistry; 1996 Jun; 35(23):7341-55. PubMed ID: 8652510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The structure of glycogen phosphorylase b with an alkyldihydropyridine-dicarboxylic acid compound, a novel and potent inhibitor.
    Zographos SE; Oikonomakos NG; Tsitsanou KE; Leonidas DD; Chrysina ED; Skamnaki VT; Bischoff H; Goldmann S; Watson KA; Johnson LN
    Structure; 1997 Nov; 5(11):1413-25. PubMed ID: 9384557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The binding of beta- and gamma-cyclodextrins to glycogen phosphorylase b: kinetic and crystallographic studies.
    Pinotsis N; Leonidas DD; Chrysina ED; Oikonomakos NG; Mavridis IM
    Protein Sci; 2003 Sep; 12(9):1914-24. PubMed ID: 12930991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystallographic and computational studies on 4-phenyl-N-(beta-D-glucopyranosyl)-1H-1,2,3-triazole-1-acetamide, an inhibitor of glycogen phosphorylase: comparison with alpha-D-glucose, N-acetyl-beta-D-glucopyranosylamine and N-benzoyl-N'-beta-D-glucopyranosyl urea binding.
    Alexacou KM; Hayes JM; Tiraidis C; Zographos SE; Leonidas DD; Chrysina ED; Archontis G; Oikonomakos NG; Paul JV; Varghese B; Loganathan D
    Proteins; 2008 May; 71(3):1307-23. PubMed ID: 18041758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The structure of a glycogen phosphorylase glucopyranose spirohydantoin complex at 1.8 A resolution and 100 K: the role of the water structure and its contribution to binding.
    Gregoriou M; Noble ME; Watson KA; Garman EF; Krulle TM; de la Fuente C; Fleet GW; Oikonomakos NG; Johnson LN
    Protein Sci; 1998 Apr; 7(4):915-27. PubMed ID: 9568898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural flavonoids as antidiabetic agents. The binding of gallic and ellagic acids to glycogen phosphorylase b.
    Kyriakis E; Stravodimos GA; Kantsadi AL; Chatzileontiadou DS; Skamnaki VT; Leonidas DD
    FEBS Lett; 2015 Jul; 589(15):1787-94. PubMed ID: 25980608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystallographic binding studies on the allosteric inhibitor glucose-6-phosphate to T state glycogen phosphorylase b.
    Johnson LN; Snape P; Martin JL; Acharya KR; Barford D; Oikonomakos NG
    J Mol Biol; 1993 Jul; 232(1):253-67. PubMed ID: 8331662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of beta-D-glucopyranosyl bismethoxyphosphoramidate to glycogen phosphorylase b: kinetic and crystallographic studies.
    Chrysina ED; Kosmopoulou MN; Kardakaris R; Bischler N; Leonidas DD; Kannan T; Loganathan D; Oikonomakos NG
    Bioorg Med Chem; 2005 Feb; 13(3):765-72. PubMed ID: 15653344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sourcing the affinity of flavonoids for the glycogen phosphorylase inhibitor site via crystallography, kinetics and QM/MM-PBSA binding studies: comparison of chrysin and flavopiridol.
    Tsitsanou KE; Hayes JM; Keramioti M; Mamais M; Oikonomakos NG; Kato A; Leonidas DD; Zographos SE
    Food Chem Toxicol; 2013 Nov; 61():14-27. PubMed ID: 23279842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.